Hide metadata

dc.date.accessioned2022-03-01T18:00:40Z
dc.date.available2022-03-01T18:00:40Z
dc.date.created2022-02-04T11:48:18Z
dc.date.issued2021
dc.identifier.citationNajafinejad, Maryam Cheraghali, Fatemeh Aghcheli, Bahman Rajabi, Abdolhalim Barati, Leila Naziri, Hamed Gharib, Mohammad Hadi Tabarraei, Alijan Nakstad, Britt Tahamtan, Alireza . COVID-19 in Pediatrics: Demographic, Clinical, Laboratory, and Radiological Characteristics of Infected Patients With SARS-CoV-2. Frontiers in pediatrics. 2021, 9
dc.identifier.urihttp://hdl.handle.net/10852/91654
dc.description.abstractThe COVID-19 disease usually leads to mild infectious disease in children, but some develop serious complications. Here, we describe the characteristics of children with COVID-19 in northern Iran, the Golestan province. Ninety-one confirmed cases were enrolled in the study, aged 0–18 years. Demographic, clinical, comorbidity, laboratory, and radiological data were compared based on the disease severity (admitted to intensive care unit (ICU) or not) and disease outcome (recovered or deceased). Sixteen (17.5%) cases were hospitalized in ICU, and 8/91 (8.8%) deceased. Fever and cough were the most common clinical symptoms. Among all symptoms notified there were no significant differences between severe and milder cases, or between those who deceased and recovered. Failure to thrive (FTT), malignant disease and neurological disease were significantly more prevalent in severe cases as was frequently reported comorbidities. Laterality, ground-glass opacity, and lung consolidation were the most common findings in chest computed tomography. The data confirms that the COVID-19 disease has various presentations in children, and clinical, laboratory, and radiological findings may help predict the development of severe forms of COVID-19 among children.
dc.languageEN
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleCOVID-19 in Pediatrics: Demographic, Clinical, Laboratory, and Radiological Characteristics of Infected Patients With SARS-CoV-2
dc.typeJournal article
dc.creator.authorNajafinejad, Maryam
dc.creator.authorCheraghali, Fatemeh
dc.creator.authorAghcheli, Bahman
dc.creator.authorRajabi, Abdolhalim
dc.creator.authorBarati, Leila
dc.creator.authorNaziri, Hamed
dc.creator.authorGharib, Mohammad Hadi
dc.creator.authorTabarraei, Alijan
dc.creator.authorNakstad, Britt
dc.creator.authorTahamtan, Alireza
cristin.unitcode185,53,46,0
cristin.unitnameBarne- og ungdomsklinikken
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin1997751
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Frontiers in pediatrics&rft.volume=9&rft.spage=&rft.date=2021
dc.identifier.jtitleFrontiers in pediatrics
dc.identifier.volume9
dc.identifier.pagecount9
dc.identifier.doihttps://doi.org/10.3389/fped.2021.808187
dc.identifier.urnURN:NBN:no-94251
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn2296-2360
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/91654/1/Nakstad_et_al_2022.pdf
dc.type.versionPublishedVersion
cristin.articleid88187


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International